Koutons Retail| Lupin Ltd

Koutons Retail

Koutons Retail India Ltd has posted a net profit of Rs 157.950 million for the quarter ended December 31, 2009 as compared to Rs 133.157 million for the quarter ended December 31, 2008. Total Income has increased from Rs 2423.035 million for the quarter ended December 31, 2008 to Rs 2697.793 million for the quarter ended December 31, 2009.

Lupin Ltd

Lupin said its US-based subsidiary Lupin Pharmaceuticals Inc has received approval from the US drug regulator for Perindopril Erbumine tablets, used in treatment of heart disease. The company has received final approval from the US Food and Drug Administration (US FDA) for its Perindopril Erbumine tablets in the strengths of 2mg, 4mg and 8mg, Lupin.

Related posts:

1. Buy Koutons Retail – Edelweiss Research
2. GE Shipping| Educomp Solutions
3. Buy Lupin, target of Rs 840: Sharekhan
4. HDIL Results
5. Aban Offshore Q3 consolidated net profit down at Rs 89.4 Cr